Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2005

View Archived Issues

Topical treatment with the novel thiazolidinedione BP-1107 reduces epidermal hyperplasia

Patients with chronic primary insomnia improve after eszopiclone therapy

Ono updates latest pipeline developments

Antitumor activity and improved toxicity of new agent to target and suppress survivin

New SK inhibitors: candidates for hyperproliferative, inflammatory and angiogenic diseases

PEP-005 Topical produces statistically significant complete clearance of AK skin lesions in phase II

LY-156735 reduces body weight, without altering food consumption

Adherex Technologies gets IND clearance for eniluracil trials

BioDelivery Sciences International plans trials for BEMA Long Acting Analgesic

Y's advances YSPSL into phase II for prevention of delayed graft function

Enrollment completed in phase III study of CellCept for myasthenia gravis

Phase II maribavir study completes enrollment

One-year trial data show fewer liver function abnormalities with sitaxsentan

European filing for bifeprunox delayed until 2008

SuppreMol launched as new company

AAGP protects skin cells from ultra violet-C radiation

XACT trial of AMD-070 now enrolling HIV patients

Vitae begins phase II study for VTP-201227 in psoriasis

Phase II trial assesses VTP-195183 in combination with G-CSF

Acambis begins phase I trial for C. difficile vaccine

New orally active MetAP2 inhibitor with promising in vivo antitumor activity

BioInvent's antibody candidate for atherosclerosis

Paliperidone ER submitted for FDA approval in schizophrenia

Korean approval for udenafil in erectile dysfunction

Polyphenon E Ointment NDA accepted for review

Spectrum selective kinase inhibitors from Exelixis evaluated in phase I trials

Phase I results encourage further investigation of SNS-595

Pfizer patents disclose compounds with potential for HIV and AIDS

Recent patents describe novel agents for metabolic disorders

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...